Generics Most of the world's population live with no more than six years or no data exclusivity at all, with regard to pharmaceutical patents. Many countries have no data exclusivity including major markets such as India and Brazil. Many countries such as Australia, New Zealand, China, Singapore, South Korea, Israel, Chile, Taiwan, Turkey, Jordan and Saudi Arabia have five or six years data exclusivity. 28 June 2011